Gene therapy with B-cell maturation antigen/CD3 bispecific antibody encoding plasmid DNA for treating multiple myeloma

被引:1
作者
Peng, Fengping [1 ]
Wang, Yuan [2 ,3 ]
Zhao, Jiliang [2 ,3 ]
Liu, Hui [1 ]
Liu, Zhaoyun [1 ]
Ding, Kai [1 ]
Zhang, Hongkai [2 ,3 ]
Fu, Rong [1 ]
机构
[1] Tianjin Med Univ, Dept Hematol, Gen Hosp, Tianjin, Peoples R China
[2] Nankai Univ, State Key Lab Med Chem Biol, Tianjin, Peoples R China
[3] Nankai Univ, Coll Life Sci, Tianjin, Peoples R China
基金
中国国家自然科学基金;
关键词
B-cell maturation antigen; bispecific T-cell engager; gene therapy; in vivo electroporation; multiple myeloma;
D O I
10.1111/bjh.18230
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The delivery of bispecific antibodies (BsAbs) targeting B-cell maturation antigen (BCMA) and CD3 using the gene therapy approach is a promising alternative for BsAb administration in patients with multiple myeloma (MM). In the present study, we evaluated the efficacy of this approach using a xenograft model. Tumour growth was significantly delayed in mice treated with single electroporation-enhanced intramuscular injection of plasmid DNA encoding BCMA/CD3 BsAb in contrast to the vehicle control-treated group. Limited toxicity was observed following treatment. This study demonstrates that the gene therapy-based approach for the delivery of BCMA/CD3 BsAb is effective and safe for the treatment of MM.
引用
收藏
页码:417 / 421
页数:5
相关论文
共 15 条
[1]   Immunotherapy Against HPV16/18 Generates Potent TH1 and Cytotoxic Cellular Immune Responses [J].
Bagarazzi, Mark L. ;
Yan, Jian ;
Morrow, Matthew P. ;
Shen, Xuefei ;
Parker, R. Lamar ;
Lee, Jessica C. ;
Giffear, Mary ;
Pankhong, Panyupa ;
Khan, Amir S. ;
Broderick, Kate E. ;
Knott, Christine ;
Lin, Feng ;
Boyer, Jean D. ;
Draghia-Akli, Ruxandra ;
White, C. Jo ;
Kim, J. Joseph ;
Weiner, David B. ;
Sardesai, Niranjan Y. .
SCIENCE TRANSLATIONAL MEDICINE, 2012, 4 (155)
[2]   In Vivo Delivery of a DNA-Encoded Monoclonal Antibody Protects Non-human Primates against Zika Virus [J].
Esquivel, Rianne N. ;
Patel, Ami ;
Kudchodkar, Sagar B. ;
Park, Daniel H. ;
Stettler, Karin ;
Beltramello, Martina ;
Allen, Jeffrey W. ;
Mendoza, Janess ;
Ramos, Stephanie ;
Choi, Hyeree ;
Borole, Piyush ;
Asija, Kanika ;
Bah, Mamadou ;
Shaheen, Shareef ;
Chen, Jing ;
Yan, Jian ;
Durham, Amy C. ;
Smith, Trevor R. F. ;
Broderick, Kate ;
Guibinga, Ghiabe ;
Muthumani, Kar ;
Corti, Davide ;
Humeau, Laurent ;
Weiner, David B. .
MOLECULAR THERAPY, 2019, 27 (05) :974-985
[3]   Intratumoral Plasmid IL12 Electroporation Therapy in Patients with Advanced Melanoma Induces Systemic and Intratumoral T-cell Responses [J].
Greaney, Samantha K. ;
Algazi, Alain P. ;
Tsai, Katy K. ;
Takamura, Kathryn T. ;
Chen, Lawrence ;
Twitty, Christopher G. ;
Zhang, Li ;
Paciorek, Alan ;
Pierce, Robert H. ;
Le, Mai H. ;
Daud, Adil, I ;
Fong, Lawrence .
CANCER IMMUNOLOGY RESEARCH, 2020, 8 (02) :246-254
[4]   A Phase 1 First in Human (FIH) Study of AMG 701, an Anti-B-Cell Maturation Antigen (BCMA) Half-Life Extended (HLE) BiTE® (bispecific T-cell engager) Molecule, in Relapsed/Refractory (RR) Multiple Myeloma (MM) [J].
Harrison, Simon J. ;
Minnema, Monique C. ;
Lee, Hans C. ;
Spencer, Andrew ;
Kapoor, Prashant ;
Madduri, Deepu ;
Larsen, Jeremy ;
Ailawadhi, Sikander ;
Kaufman, Jonathan L. ;
Raab, Marc S. ;
Hari, Parameswaran ;
Iida, Shinsuke ;
Vij, Ravi ;
Davies, Faith E. ;
Lesley, Robin ;
Upreti, Vijay V. ;
Yang, Zhao ;
Sharma, Anjali ;
Minella, Alex ;
Lentzsch, Suzanne .
BLOOD, 2020, 136
[5]   Development of Novel DNA-Encoded PCSK9 Monoclonal Antibodies as Lipid-Lowering Therapeutics [J].
Khoshnejad, Makan ;
Patel, Ami ;
Wojtak, Krzysztof ;
Kudchodkar, Sagar B. ;
Humeau, Laurent ;
Lyssenko, Nicholas N. ;
Rader, Daniel J. ;
Muthumani, Kar ;
Weiner, David B. .
MOLECULAR THERAPY, 2019, 27 (01) :188-199
[6]   Gene therapy using plasmid DNA-encoded anti-HER2 antibody for cancers that overexpress HER2 [J].
Kim, H. ;
Danishmalik, S. N. ;
Hwang, H. ;
Sin, J-I ;
Oh, J. ;
Cho, Y. ;
Lee, H. ;
Jeong, M. ;
Kim, S-H ;
Hong, H. J. .
CANCER GENE THERAPY, 2016, 23 (10) :341-347
[7]   Improved survival in multiple myeloma and the impact of novel therapies [J].
Kumar, Shaji K. ;
Rajkumar, S. Vincent ;
Dispenzieri, Angela ;
Lacy, Martha Q. ;
Hayman, Suzanne R. ;
Buadi, Francis K. ;
Zeldenrust, Steven R. ;
Dingli, David ;
Russell, Stephen J. ;
Lust, John A. ;
Greipp, Philip R. ;
Kyle, Robert A. ;
Gertz, Morie A. .
BLOOD, 2008, 111 (05) :2516-2520
[8]   Regulated control of gene therapies by drug-induced splicing [J].
Monteys, Alex Mas ;
Hundley, Amiel A. ;
Ranum, Paul T. ;
Tecedor, Luis ;
Muehlmatt, Amy ;
Lim, Euyn ;
Lukashev, Dmitriy ;
Sivasankaran, Rajeev ;
Davidson, Beverly L. .
NATURE, 2021, 596 (7871) :291-+
[9]   MEDICAL PROGRESS Multiple Myeloma [J].
Palumbo, Antonio ;
Anderson, Kenneth .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (11) :1046-1060
[10]   Recent updates on bispecific T-cell engager (BiTE) antibodies in relapsed and refractory multiple myeloma. [J].
Rafae, Abdul ;
Wahab, Ahsan ;
Ehsan, Hamid ;
Christy, Joshua ;
Saleem, Tabinda ;
Kandah, Emad ;
Ali, Rabia ;
Malik, Mustafa Nadeem ;
Ali, Sundas ;
Saeed, Sara ;
Anwer, Faiz .
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)